Phase 1Completed
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics of Minocin® (Minocycline) for Injection in Healthy Adult Subjects
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) (Industry)
- Enrolment
- 69 enrolled
- Conditions
- Normal Healthy Volunteers
- Interventions
- Minocin (minocycline) for Injection; Placebo
- Ages
- adults
- Registry
- NCT02802631
Full record on ClinicalTrials.gov
From the registry
This was a Phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study of the safety, tolerability, and pharmacokinetics of Minocin (minocycline) for injection in healthy adult participants.
Primary outcomes
- Number Of Participants Experiencing Treatment-emergent Adverse Events
History
Last registry update
Results first posted
Primary completion
Started
Registered